Inherited Cancer Screening
With next-generation genetic sequencing technology, LifeBrite Labs can now screen your patients for pathogenic genetic variants which may put them at a higher risk of developing certain kinds of cancer. Empowered with this information, you and your patients can then discuss appropriate preventative measures.
LifeBrite offers test panels for breast cancer, prostate cancer, pancreatic cancer, gastric cancer, melanoma, lung cancer, renal cancer, and tumor syndromes, as well as a comprehensive cancer panel.
The medical community has witnessed the firsthand benefits of pre-cancer screenings for patient populations especially with cervical cancer. According to the CDC, cervical cancer was once “the leading cause of cancer death for women in the United States.” Papanicolaou (Pap) tests began to be more widely used in cervical screenings in the 1950s and 1960s, and, as a result, by 2009, cervical cancer incidence and mortality was down by 75%. The benefits of pre-screening are undeniable, and Lifebrite’s genetic sequencing technology is the next step in the evolution of preventative cancer tests in healthcare.